Picard Medical, Inc. (PMI)
| Market Cap | 11.43M |
| Revenue (ttm) | 5.47M +80.5% |
| Net Income | -28.28M |
| EPS | -0.54 |
| Shares Out | 92.35M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,661,653 |
| Open | 0.1374 |
| Previous Close | 0.1402 |
| Day's Range | 0.1213 - 0.1374 |
| 52-Week Range | 0.1100 - 13.6800 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 15, 2026 |
About PMI
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard ... [Read more]
Financial Performance
In 2025, Picard Medical's revenue was $4.94 million, an increase of 12.50% compared to the previous year's $4.39 million. Losses were -$27.00 million, 13.8% more than in 2024.
Financial StatementsNews
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on July 16, 2026, providing details for shareholder voting and corporate governance matters.
Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program
Peer-reviewed journal's News section highlights the Company's continued progress toward a fully implantable total artificial heart Peer-reviewed journal's News section highlights the Company's continu...
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration Presentation Highlights Business Progress, Product Development Milestones, and Matt...
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on July 8, 2026, providing details for shareholder voting and corporate governance matters.
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on June 29, 2026, providing details for shareholder voting and corporate governance matters.
Picard Medical CEO Patrick Schnegelsberg steps down
Picard Medical (PMI) announced a leadership transition. Patrick Schnegelsberg has stepped down as CEO and as a member of the company’s board of directors, effective June 18. The company said…
Picard Medical Announces Leadership Transition
TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the wor...
U.S. Bank Names Eric Levine to Lead Healthcare Payments
MINNEAPOLIS--(BUSINESS WIRE)--Eric Levine has joined U.S. Bank to lead the bank's strategy to deliver more connected treasury, payments and merchant solutions to healthcare organizations. As head of h...
WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) and WSJ Intelligence, the in-house thought leadership consultancy for The Wall Street Journal's commercial sales organizatio...
Philip Morris International Announces New Regional Leadership
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) announced a series of regional leadership appointments that support its ongoing shift toward a smoke‑free future. Effective ...
Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026
TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the wor...
Picard Medical Proxy statement: Proxy filing
Picard Medical filed a proxy statement on June 15, 2026, providing details for shareholder voting and corporate governance matters.
Picard Medical advances Emperor total artificial heart program
The company states: “Picard Medical (PMI) announced the successful completion of an acute in vivo implant study series using the Company’s next-generation Emperor Total Artificial Heart Platform at th...
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —
PICARD MEDICAL, INC. Issues Letter to Shareholders
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world's first and o...
Picard Medical / SynCardia Reports First Quarter 2026 Financial Results
– Gross profit turns positive; Company executes significant debt reduction – -- Responds to NYSE American continued listing notice - TUCSON, Ariz., May 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc...
Picard Medical registers to sell 16.21M shares of common stock for holders
This filing relates to the offer and sale from time to time by the selling stockholder of up to 16.21M shares of common stock. The company is not selling any…
Picard Medical Registration statement: Registration filing
Picard Medical filed a registration statement on May 20, 2026, providing details about a securities offering with the SEC.
Picard Medical initiated with a Neutral at H.C. Wainwright
H.C. Wainwright initiated coverage of Picard Medical (PMI) with a Neutral rating without a price target Picard is a holding company that owns 100% of SynCardia Systems, the manufacturer of…
Picard Medical Quarterly report: Q1 2026
Picard Medical has published its Q1 2026 quarterly earnings report on May 15, 2026.
Picard Medical Earnings release: Q1 2026
Picard Medical released its Q1 2026 earnings on May 15, 2026, summarizing the period's financial results.
Picard Medical Announces Pricing of $5 Million Offering
TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart a...
Picard Medical Registration statement: Registration filing
Picard Medical filed a registration statement on May 1, 2026, providing details about a securities offering with the SEC.
Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology
Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart therapy Banner Health has performed more than 50 S...
Picard Medical / SynCardia Featured in Interview Series with The Mullings Group
– Discussions to highlight total artificial heart therapy, advanced heart failure market, and next-generation platform development – TUCSON, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, I...